About

Established in 2015, Spirit Scientific is dedicated to providing high-efficacy and stable preparations that promote autologous healing, alongside lyophilization services for biological materials. This is achieved through our independent cleanroom laboratory, patented technologies, and innovative service models. After 10 years of cultivation in the precision regenerative medicine market, Spirit Scientific has emerged as the leading brand in platelet lyophilization technology.

Spirit Scientific pioneered its Biofoundry™ platform, developing the BMLT (Bio-Material Lyophilized Technology) to provide pharmaceutical-grade preparation services. Starting with the extraction of high-concentration platelet-derived growth factors, we customize and optimize the lyophilization process for various biomaterials. We are continuously developing diverse applications, redefining the standards of precision regenerative medicine.

Our team, distinguished by its forward-thinking vision and extensive experience, has successfully translated our patented technologies into a viable commercial model. In collaboration with over a thousand medical institutions, we offer a novel therapeutic option that is precisely dosed, safe, reliable, versatile in application, and allows for long-term storage at ambient temperatures. Our mission is to empower both physicians and patients to realize the immense potential of platelets.

In addition to our core services, such as the preparation of autologous high-concentration lyophilized platelets, Spirit Scientific is also open to various business collaborations, including Contract Development and Manufacturing Organization (CDMO) and Original Equipment/Design Manufacturer (OEM/ODM) partnerships.